Acumen Pharmaceuticals, Inc. (ABOS) Free cash flow 2021–2025
Acumen Pharmaceuticals, Inc. (ABOS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$115.6MFY2025 · since FY2021: -$18.0M → -$115.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$115.6M | -34.1% |
| FY2024 | -$86.2M | -100.1% |
| FY2023 | -$43.1M | -22.0% |
| FY2022 | -$35.3M | -96.2% |
| FY2021 | -$18.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice